Evidence lead: Ranks four through six · High appeal-filing share
Tufts Health Plan MA: Appeals followed a large share of denials
927 appeals equal 15.0% of this contract's recorded denials. That is rank #5 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks four through six · High appeal-filing share
Appeals followed a large share of denials
927 appeals equal 15.0% of this contract's recorded denials. That is rank #5 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks twenty-one through twenty-five · Lower-middle reversal reach
Reversals covered a below-median share of denials
The 630 recorded reversals amount to 10.2% of this contract's denied requests. The cross-contract rank is #25 of 37. This derived measure combines appeal filing and outcome, so it supplies scale context but does not identify clinical reasons, administrative errors, or coverage rules.
Ranks twenty-one through twenty-five · Lower-middle overturn cohort
Appeal overturns sat below the table midpoint
This contract records a 68.0% overturn rate among filed appeals. Its overturn-rate rank is #24 of 37. The denominator is filed appeals, not all authorization requests. The percentage therefore describes reviewed appeals and must not be read as an individual outcome forecast.
Ranks twenty-one through twenty-five · Moderate request-volume cohort
A mid-lower authorization workload
This contract's 87,000 requests form a moderate comparison base within the table. Its request-volume rank is #22 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.
Ranks sixteen through twenty · Upper-middle denial cohort
Above the center of the denial-rate ordering
The recorded 7.1% denial rate falls in the upper-middle portion of the contract set. The exact rank is #19 of 37. This is aggregate prior-authorization activity for the reporting window, not a probability that a particular service, drug, or beneficiary request will be denied.